Welcome to our dedicated page for Velo3D SEC filings (Ticker: VLD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Velo3D’s SEC disclosures read like a blueprint for building parts with lasers and computational geometry, yet investors still need to decipher revenue drivers across aerospace, energy, and defense orders. If you’ve ever asked, “Where can I find Velo3D’s quarterly earnings reports?” or struggled to locate Velo3D insider trading Form 4 transactions buried in EDGAR, you’re not alone. Complex cost-of-goods schedules and hardware backlog tables can hide critical clues.
Stock Titan’s AI-powered summaries break down every filing—from a Velo3D quarterly earnings report 10-Q filing to a sudden 8-K—into plain language. Our engine tags Velo3D Form 4 insider transactions real-time, highlights segment margins, and even connects R&D spend to upcoming printer launches. Search phrases like “understanding Velo3D SEC documents with AI” or “Velo3D annual report 10-K simplified” resolve to concise explanations, footnote translations, and downloadable tables, all refreshed the moment a document hits EDGAR.
Need quick context before a trade? Compare Velo3D executive stock transactions Form 4 with supply-chain risk factors, scan the proxy for Velo3D proxy statement executive compensation metrics, or review Velo3D 8-K material events explained in minutes. Every chart links back to the original pages so you can verify numbers without scrolling 300 pages. No more hunting; the complete Velo3D SEC filings explained simply are organized, searchable, and ready for deeper Velo3D earnings report filing analysis.
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ: SONN) filed an 8-K announcing a $2.0 million private placement of zero-interest convertible notes and accompanying warrants. The notes, issued on 30 June 2025, mature on 30 June 2026 and can be converted at any time into up to 1,730,104 common shares at a fixed price of $1.156.
Investors also purchased five-year warrants for 865,052 shares at the same $1.156 exercise price, providing approximately $50,000 additional cash proceeds. If the company completes a subsequent equity raise of at least $5.0 million, any outstanding principal will automatically convert into the securities offered in that financing. Should such a financing not occur within 90 days, investors may buy an extra 3,460,208 warrants at $0.25 per share, and Sonnet must file a registration statement covering all underlying securities.
Ownership limits of 4.99%, 9.99% or 19.99% (at each investor’s election) apply to both note conversions and warrant exercises. The securities were issued under Sections 4(a)(2) and/or Rule 506(b) of Regulation D. Exhibit filings include the form of Convertible Note (Ex. 4.1) and Warrant (Ex. 4.2).
- Total immediate proceeds: $2.05 million.
- Potential future dilution: up to 6.06 million shares if all notes convert and all warrants (initial and contingent) are exercised.
- No cash interest expense until maturity, but notes represent a direct financial obligation.
Velo3D Director Kenneth Dale Thieneman received a grant of 24,331 Restricted Stock Units (RSUs) on May 28, 2025, as reported in this Form 4 filing. The RSUs represent his initial equity award following his appointment to the Board of Directors.
Key details of the RSU grant:
- Each RSU converts to one share of Velo3D common stock upon settlement
- The RSUs vest in full on the first anniversary of the grant date (May 28, 2026)
- Vesting is contingent on Thieneman's continued service as a director
- The RSUs were granted at no cost ($0)
The transaction was reported through an attorney-in-fact, Roma Kumar, and filed on June 18, 2025. This grant aligns with typical board compensation practices, providing equity incentives to align director interests with shareholders.
FAQ
What is the current stock price of Velo3D (VLD)?
What is the market cap of Velo3D (VLD)?
What is the core business of Velo3D, Inc.?
How does Velo3D generate revenue?
What distinguishes Velo3D from traditional 3D printing companies?
What industries benefit from Velo3D's technology?
What are the key technological innovations behind Velo3D's systems?
How does Velo3D maintain quality in its additive manufacturing processes?
